Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
2021 · Signal Transduction and Targeted Therapy · 59 citations
https://doi.org/10.1038/s41392-021-00861-4
X
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
6.4K
Citations
27
h-index
52
i10-index
Xiaofeng Li is an academic researcher from First Affiliated Hospital of Henan University of Science and Technology. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 27, co-authored 137 publications.
ORCID: 0000-0001-5155-8475Papers by this author
worksCopper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
2024 · Proceedings of the National Academy of Sciences · 58 citations
https://doi.org/10.1073/pnas.2311630121
A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters
2022 · The Innovation · 22 citations
https://doi.org/10.1016/j.xinn.2022.100221
Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria
2024 · The ISME Journal · 12 citations
https://doi.org/10.1093/ismejo/wrae146
Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing
2022 · Infectious Medicine · 6 citations
https://doi.org/10.1016/j.imj.2022.04.003
Relationship between Helicobacter pylori infection and digestive tract diseases and analysis of risk factors: a cross-sectional study based on 3867 Chinese patients
2024 · Aging · 5 citations
https://doi.org/10.18632/aging.206065
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat